Bringing Stability to APIs Under Stress
By Stephanie Vine
September 2, 2025
Researchers develop new tool for evaluating API stability under various conditions.
2 min read
False
By Stephanie Vine
September 2, 2025
Researchers develop new tool for evaluating API stability under various conditions.
2 min read
September 2, 2025
The future of biologics is high-dose, low-volume, and delivery via patient centric devices. But developing stable formulations for these high-concentration biologics comes with challenges.
6 min read
September 1, 2025
Orbital experiments are tackling formulation problems, testing monoclonal antibodies, and changing how we think about drug development and crystallization.
4 min read
August 26, 2025
The EMA has maintained its faith in the safe use of titanium dioxide for pharmaceutical applications, but suggests that companies should look into alternatives.
2 min read
August 22, 2025
Early API development can drive environmental gains without sacrificing speed or yield.
8 min read
By Marwan Alsarraj
August 21, 2025
RNA therapeutics are advancing rapidly, but their clinical success depends on the availability of precise, reliable analytical methods.
11 min read
By Hilary Brooks
August 20, 2025
Pharma is investing big in oligonucleotides, but what is it that makes this class of drugs so special? We find out.
10 min read
August 18, 2025
Stable isotope ratio mass spectrometry used to assess drug authenticity and consistency.
3 min read
By Corey Ohnmacht, Suzanne Jansen
August 15, 2025
Looking at the importance of stability programs in early clinical drug product development.
4 min read
August 15, 2025
What should the industry do to tackle nitrosamines? It comes down to excipient selection, process control, and predictive tools.
7 min read
False
False
False